^
    BIOMARKER:

    MYC rearrangement + BCL2 rearrangement

    i
    Other names: MYC, bHLHe39, c-Myc, MYCC, V-myc avian myelocytomatosis viral oncogene homolog, BCL2, Bcl-2, PPP1R50, B-cell CLL/lymphoma 2




    Show legend

    Include preclinical:
    Diffuse Large B Cell Lymphoma
    Lymphoma
    Follicular Lymphoma
    Non-Hodgkin’s Lymphoma
    lisocabtagene maraleucel
    EPOCH-R
    R-DHAP
    C-RICE
    lenalidomide
    AR160
    ibrutinib
    lenalidomide + zanubrutinib
    loncastuximab tesirine-lpyl
    axicabtagene ciloleucel
    BTM-3566
    IACS-010759
    SGN-CD19B
    ibrutinib + alemtuzumab
    HZX-02-059
    venetoclax
    copanlisib
    venetoclax + DUP 785
    rituximab
    cytarabine + methotrexate